phaeochromocytoma
Table of Contents
phaeochromocytoma
Introduction
- pheochromocytomas arise from chromaffin cells and which secrete catecholamines
- they are rare tumours, arising in only 2-8 people per million population
- 85% arise from the adrenal (11% are malignant), 15% arise from extra-adrenal sources such as sympathetic ganglia (30% are malignant)
- accounts for ~10% of adrenal masses and 10% of cases are bilateral - see adrenal tumours
- 15–20% are hereditary
- mostly occurs in young or middle age adults
- they were 1st described in 1886 by Felix Fränkel, and the name was coined by Ludwig Pick in 1912
Diagnosis
- often evident from clinical picture:
- episodic hypertension, headache, sweating, palpitations, anxiety, pallor and tremors
- may cause adrenergic storm
- may be associated with endocrine syndromes such as:
- neurofibromatosis
- von Hippel-Lindau disease (retinal angiomas) - this accounts for 5% of cases
- multiple endocrine neoplasm II (medullary thyroid carcinoma)
- easy to detect on MRI
- diagnostic tests include:
- plasma catecholamines (>2000 pg/mL) - lower levels may require further Ix such as a clonidine suppression test
- 24hr urinary metanephrines >1.6 mg/24 hr
- NB. metamphetamine (ice) users may also have high urinary metanephrine levels and thus should have a week of abstinence before re-testing
DDx
- withdrawal syndromes eg. opiate withdrawal
- paragangliomas
- alpha adrenergic agonists toxicity / overdose
- other causes of excess catecholamine / sympathomimetic activity may cause a false positive urine catecholamine or metanephrine test:
- stress / exertion
- methyldopa, ganglion blockers
- stimulants including caffeine
- dopamine agonists
Rx
- Rx is usually surgical resection but there is a considerable risk of profound hypotension post-op which is usually prevented by measures such as pre-op salt loading
- 3% recur
- patients have a relative risk of 3-4x of secondary cancers
phaeochromocytoma.txt · Last modified: 2022/06/07 03:20 by gary1